AN-132

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameAN-132
Drug Alias NameAN-132
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersPotassium channel blockersVoltage-gated calcium channel blockers
TargetsPotassium channelSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A